ABSTRACT Flexible linkers are often found to tether binding sequence motifs or connect protein domains. Here we analyze three usages of flexible linkers: 1), intramolecular binding of proline-rich peptides (PRPs) to SH3 domains for kinase regulation; 2), intramolecular binding of PRP for increasing the folding stability of SH3 domains; and 3), covalent linking of PRPs and other ligands for high-affinity bivalent binding. The basis of these analyses is a quantitative relation between intermolecular and intramolecular binding constants. This relation has the form K i ¼ K e0 p for intramolecular binding and K e ¼ K e01 K e02 p for bivalent binding. The effective concentration p depends on the length of the linker and the distance between the linker attachment points in the bound state. Several applications illustrate the usefulness of the quantitative relation. These include intramolecular binding to the Itk SH3 domain by an internal PRP and to a circular permutant of the a-spectrin SH3 domain by a designed PRP, and bivalent binding to the two SH3 domains of Grb2 by two linked PRPs. These and other examples suggest that flexible linkers and sequence motifs tethered to them, like folded protein domains, are also subject to tight control during evolution.
INTRODUCTION
Unstructured regions of proteins increasingly are found to play regulatory and signaling roles (1, 2) . One mode of action is through the binding of a peptide motif within an unstructured region to a target protein domain. Many such peptide motifs have been identified (3) . Prominent among these is a proline-rich peptide (PRP) that binds to SH3 domains. X-ray structures of Src, Hck, and Abl kinases (4) (5) (6) (7) (8) show that intramolecular binding to the SH3 domain by a PRP within the linker between the SH2 and kinase domains provides an important mechanism for suppression of kinase activity (Fig. 1 a) . These structures also immediately suggest a mechanism for kinase activation through intermolecular PRPbinding to the SH3 domain, leading to the release of the SH3 domain from the intramolecular PRP (Fig. 1 b) . Previously we have developed a quantitative relation between intermolecular and intramolecular binding and applied the relation to examine the effects of covalent linking in protein folding stability (9) and in protein-DNA and antibody-antigen binding affinity (10, 11) as well as the role of intramolecular binding of the myristoylated N-terminal in Abl kinase regulation (12) . In this article we apply the relation to rationalize a number of recent experimental results on intramolecular PRP-SH3 binding in kinase regulation and on enhancement of folding stability and binding affinity through covalent linking of PRP ligands.
One type of intramolecular binding studied here is between a PRP connected to an SH3 domain via a flexible linker (Fig. 1 c) . In particular, this models the arrangement of PRP and SH3 domains in the Tec family of nonreceptor tyrosine kinases (13) (14) (15) (16) (17) and in the diphtheria toxin repressor (18) . The quantitative relation between intermolecular and intramolecular binding suggests that, while there is evolutionary pressure to increase the binding affinity of SH3 domains for external PRP from target proteins, it may be advantageous to maintain the affinity for internal PRP at a relatively low level. Hence in Src, Hck, and Abl kinases the sequences of internal PRP deviate significantly from those of high-affinity ligands (19, 20) . Similarly, a PRP within Btk, a member in the Tec family of kinases, was found to bind with the SH3 domains of Fyn, Hck, and Lyn kinases, but not with Btk's own SH3 domain (21) . Indeed, the binding constants of Tec family kinases for their internal PRPs are typically found to be of the order of 10 3 M ÿ1 (15) (16) (17) . In contrast, the affinity of SH3 domains for PRPs on target proteins can reach 10 6 M ÿ1 or higher (22) (23) (24) (25) (26) . The binding site for PRP is formed only when the SH3 is folded. Therefore in a folding transition PRP-binding can shift the equilibrium from the unfolded to folded state. The presence of an intramolecularly bound PRP is thus expected to increase the folding stability of the SH3 domain. Such stabilization has been observed in SH3 domains with designed intramolecular PRPs (27, 28) . The quantitative relation between intermolecular and intramolecular binding allows for calculation of the effect of the intramolecular PRPs on the unfolding free energy.
When a protein has multiple binding sites, a high-affinity ligand can be obtained by covalently linking peptide motifs that target the individual binding sites. Such bivalent ligands have been designed to simultaneously bind to the SH3 and SH2 domains of Abl kinase (29, 30) , the SH2 and kinase domains of Src kinase (31, 32) , and the two SH3 domains of Grb2 (33) (34) (35) . In each of these cases there is strong experimental evidence indicating rearrangement between the domains upon ligand binding (6, 32, 34, 36) . Previously the affinity-enhancement role of covalent linking has been analyzed for one of these ligands without considering the effect of domain rearrangement (11) . Here this effect is incorporated to analyze the affinity of bivalent ligands. The analysis helps dispel misconception regarding bivalent binding that has appeared in the literature and provides an indication on the range of affinity enhancement expected from bivalent binding.
THEORY

Binding of PRP to SH3 domain, with and without flexible linker
When a PRP is attached to an SH3 domain by a flexible linker, the intramolecular binding constant K i can be related to the intermolecular binding constant K e0 , observed when the linker is cleaved (Fig. 2 a) . Under the assumption that the PRP and the SH3 domain do not interfere with the statistical distribution of the linker, except that the binding restrains the endto-end distance of the linker to a distance d, it was shown (10,37)
where p(d) is the probability density for the end-to-end vector of the linker at the distance d. The value p(d) plays the role of effective concentration. It has been found that peptide linkers can be modeled well as wormlike chains (38) . For a linker consisting of L peptide bonds, an approximate expression for p(d) is then where l c and l p are the contour length and persistence length, respectively, of the peptide linker. The contour length can be calculated as bL, where b ¼ 3.8 Å is the nearest C a -C a distance. The persistence length was found to be ;3 Å for peptide linkers.
Cross-binding and dimerization
An SH3 domain can bind with not only its internal PRP but also the PRP on another molecule. Let us consider the general case of cross-binding between two different types of PRP-SH3 molecules. As illustrated in Fig. 2 
Note that Eqs. 3c-e require
When the two types of PRP-SH3 molecules are present at the same total concentration C t , one finds
where f(K a C t ) is the monomer fraction in a simple monomer-dimer equilibrium
The apparent dimerization constant in the present situation is given by
Suppose that the binding equilibria are monitored by a signal-like chemical shift. For the simple monomer-dimer equilibrium, if the signals of pure monomer and pure dimer are s m and s d , then the signal at a total monomer concentration of C t is
Let us assume that, for each type of SH3 domain, the bound species all give the same signal s ba (a ¼ 1 or 2) and the unbound species all give the same signal s ua . At equilibrium the actual signals from the two types of molecules are
These can be expressed in the same form as Eq. 7, with the apparent monomer and dimer signals given by 
for a ¼ 1 or 2.
The cross-binding model of Fig. 2 b has six binding constants. To gain further insight on these binding constants, let us consider a control experiment in which the linkers on the two types of PRP-SH3 molecules are cleaved and bimolecular binding of the two types of PRP to each of the two types of SH3 domains is then observed. Let the binding constants of SH3 domain a for the internal and external PRP be K ea0 and K e9a0 , respectively. The cross-binding constant K ea can be approximated by K e9a0 . The intramolecular binding constant K ia can be related to K ea0 through Eq. 1,
Here, d a is the distance between the attachment point of the linker and the PRP binding site on SH3 domain a, and L a is the linker length. An analogous relation between the intramolecular binding constant K9 i1 , for forming D bb from D ub, and K e10 can be proposed,
where
is the probability density for the end-to-end vector of a composite linker, consisting of the flexible peptide (with length L 1 ) attached to the first SH3 domain, a rigid connector with length d 2 , and the flexible peptide (with length L 2 ) attached to the second SH3 domain. Similarly,
Since the two SH3 domains will have excluded-volume interactions and perhaps even specific interactions, the last two relations may not be very accurate. It can be shown that 
is the binding constant if only one of the two identical PRP on D d were allowed to release. With these considerations, the results derived earlier for heterodimerization can be easily adapted for the present homodimerization process. The apparent dimerization constant is
The signals at zero and infinite protein concentration are
Folding of PRP-SH3 molecule
To understand the equilibrium of a PRP-SH3 molecule between the unfolded and folded states, it is convenient to introduce an intermediate (either fictitious or real), in which the SH3 is folded by itself but the PRP is not bound (Fig. 2 c) . If the folding equilibrium constant for the SH3 domain alone is K f0 and the intramolecular PRP binding constant is K i , then the overall folding equilibrium constant is 
K f0 can be mimicked by the folding equilibrium constant of the SH3 with the PRP cleaved. The effect of the PRP on the unfolding free energy is thus
K i can be obtained, by Eq. 1, from the intermolecular binding constant K e0 of the SH3 domain for the cleaved PRP. Hence,
Since the SH3 domain autonomously folds and the PRP binding site is presented only after the SH3 domain is folded, it is reasonable to consider the intermediate as real and on-pathway. It can be further suggested that the transition state for the SH3 domain is also the transition state for the PRP-SH3 molecule. Then the overall folding and unfolding rate constants are related to those of the SH3 domain by
That is, the PRP only affects the unfolding rate.
Binding of bivalent ligand
Consider two ligands that bind to separate binding sites on the same target protein with binding constants K e01 and K e02 . If the two ligands are connected by a linker (Fig. 2 d) , then the bivalent ligand will have affinity
With K e1 % K e10 and Eq. 1 for K i2 , one arrives at the result derived previously (10, 11) ,
where p(d) is the probability density for the end-to-end vector of the linker at the distance d separating the two binding sites. When the two binding sites are located on two domains connected by a flexible linker (Fig. 2 d) , the binding constant between the linked domains and the bivalent ligand is
With K e2 % K e20 and Eq. 10c for K9 i1 , one arrives at
where L 1 and L 2 are the lengths of the linkers connecting the two target domains and the two ligands, d a is the distance between the attachment point of the interdomain linker and the ligand-binding site on domain a, and the meaning of the probability density
has been given after Eq. 10b. This formulation can be further extended when the two domains are not connected directly by a single flexible linker but by linkers from both sides to yet a third domain, like the situation between the two SH3 domains in Grb2.
Calculation of probability density
In previous studies of the relation between intermolecular and intramolecular binding (9) (10) (11) (12) , the probability density p(d) was estimated by Eq. 2. In addition, the peptide linker was allowed to start in any direction off the attachment point on a protein domain or a ligand. To improve on both aspects, here we used conformation sampling of the peptide linker to calculate p(d).
The wormlike chain modeling a peptide linker was represented as a freely rotating chain with a bond-length approaching zero and a bond-angle approaching 180° (39) . In our implementation, each chain was represented by J ¼ 1000 bonds, with a bond-length s ¼ l c /J and a bond-angle of u ¼ acos(s/l p -1). The C a -C a vectors immediately before and immediately after the peptide linker were used to enforce directionality of the start bond (i.e., bond 1) and end bond (i.e., bond J) of the linker. For concreteness, suppose that sequentially the SH3 domain is followed by the linker and then by the PRP. Let the residue number of the last SH3 residue be n s and the residue number of the first PRP residue be n e . The C a -C a vector v s from residue n s ÿ 1 to residue n s constrains the direction of bond 1 of the linker, and the C a -C a vector v e from residue n e to residue n e 1 1 constrains the direction of bond J of the linker. In the unbound state, v s and v e would have arbitrary relative orientations, but in the bound state the relative orientation of v s and v e is fixed. In addition, the end-to-end vector of the linker, identical to the C a -C a vector d from residue n s to residue n e , is also fixed relative to v s and v e . To emphasize that the directionality of the start and end bonds of the linker is constrained, the probability density of the end-to-end vector is now denoted as p(d).
The enforcement of directionality for the start and end bonds and the calculation of p(d) were implemented as follows. A wormlike chain was started at the origin with bond 1 at an arbitrary direction. After growing the chain to bond J, the end-to-end vector of the chain was lined up with d. Upon this lineup, if the angle between bond 1 and vector v s and the angle between bond J and vector v e were both less than a constraint angle g c , then the chain conformation was accepted. For each calculation of p(d), a total of N conf ¼ 10 7 chain conformations were started. Of these, the number of chains with start and end bonds satisfying directionality constraints and with end-to-end distances falling between d -D/2 and d 1 D/2 was obtained. Let this be n(d). The probability density p(d) was found as
2 N conf . The bin size D was 10 ÿ2 l c .
The corresponding probability density for a composite linker, with directionally constrained start and end bonds for the flexible components, is now denoted as
The composite linker consists of a flexible chain with length L 1 , a rigid connector spanned by vector d 2 , and another flexible chain with length L 2 . In the bound state, the two flexible chains link up two domains. The directions of the start bond of chain 1 and the end bond of chain 2 are constrained by vectors v s1 and v e1 , respectively, which are fixed in the first domain. Similarly, the directions of the end bond of chain 1 and the start bond of chain 2 are constrained by vectors v e2 and v s2 , respectively, which are fixed in the second domain.
The procedure for obtaining p 1 (d 1 ;L 1 ,d 2 ,L 2 ) was the same as that for p(d), with vector d 2 treated as a special bond. Each flexible chain was represented by J ¼ 1000 bonds. After the J th bond of chain 1, vector v e2 was randomly distributed within a cone that spans an angle g c around bond J. Vector d 2 was then randomly distributed around vector v e2 , keeping the angle between them as found in the second domain. The directions of v e2 and d 2 allowed for unique positioning of v s2 . Finally chain 2 was started off randomly within a cone that spans an angle g c around v s2 . This procedure was extended to Grb2 by an additional flexible linker followed by a rigid domain.
A value of 90°was assigned to the constraint angle g c . The persistence length of any flexible chain connected to a PRP ligand was 3 Å . For linkers between two protein domains, the value of l p was 10 times higher.
RESULTS
Intermolecular and intramolecular PRP binding of Itk, Rlk, and Btk SH3 domains Andreotti et al. (13) found that the SH3 domain of Itk forms an intramolecular complex with the K 3 KPLPPTP 10 sequence located at the N-terminal (Fig. 3 a) . , between the PRP and the sharp turn at the N-terminal of the SH3 domain. This linker sequence is shown as black ball-and-stick in Fig. 3 a. The end-to-end distance d, measured between the C a atoms of residues P 10 and L 24 , is 22.5 Å . With L ¼ 14 peptide bonds, the effective concentration p(d) was found by conformational sampling to be 13.5 mM. Equation 1 then predicts K i ¼ 0.17 3 10 3 M ÿ1 3 13.5 mM ¼ 2.3. This is to be compared with the experimental value of 0.54 6 0.1 obtained by Laederach et al. (17) . Laederach et al. (17) also studied the effect of deleting five residues, S 16 FQEP 20 , of the linker sequence. With L reducing from 14 to 9, we find p(d) lowering to 3 mM and predict K i ¼ 0.5. This is to be compared with the experimental value of 0.11 6 0.05. The much lower value of p(d) arises from the low probability for the end-to-end vector of the shortened linker to span a large distance of 22.5 Å .
Laederach et al. (17) did not find evidence for Itk PRP-SH3 dimerization at protein concentrations up to 1 mM. Equation 11 gives the apparent dimerization constant K a . Neglecting the unknown K9 i , we find K a % 2K e0 / (1 1 K i ) 2 ¼ 0.14 3 10 3 M ÿ1 . At C t ¼ 1 mM, the monomer fraction is expected to be 81% Eq. 5b. Apparently, weak intermolecular binding and relatively strong intramolecular binding work together to keep dimerization at a low level for Itk PRP-SH3.
Laederach et al. (17) also studied the binding of PRP sequence QPSKRKPLPPLP in the Rlk SH3 domain. The bimolecular binding constant of this PRP was (1.2 6 0.1) 3 10 3 M ÿ1 . The intramolecularly bound fraction (i.e., K i /(1 1 K i )) of the PRP was very low, at 0.07 6 0.1. The corresponding K i value is 0.075. Without a structure of the intramolecular complex, it is not possible to quantitatively explain the small K i value. However, Laederach et al. (17) found the intramolecularly bound fraction of the QPSKRKPLPPLP sequence increasing to 0.25 6 0.05 (K i ¼ 0.33) when five residues were inserted in the linker sequence; this increase can be qualitatively explained by the expected increase in p(d). From sequence alignment between Rlk and Itk over the PRP and SH3 regions (Fig. 3 a) , the native linker sequence of Rlk may be identified as QEPPDERI. The insertion of five residues within this sequence increases the linker length from 9 to 14.
In a separate article, Laederach et al. (16) studied PRP binding of the Btk SH3 domain. This SH3 domain is preceded by two PRP sequences (KKPLPPTP and KKPLPPEP; Fig. 3 a) . Only the first PRP, separated from the SH3 domain by a longer sequence, was found to be capable of intramolecular binding, even though both PRPs were found to be capable of cross-binding to a different SH3 domain. The increase in K i , from not measurable for the second PRP to 0.29 for the first PRP, with the increase in linker length, is similar to the situations with Itk and Rlk kinases. The bimolecular binding constant K e0 can be obtained as half of the apparent dimerization constant of the Pr*PrSH3 mutant, which is incapable of intramolecular binding within either the monomer or the dimer (i.e., In all the Tec family kinases, the bimolecular binding constant K e0 is found to be of the order of 10 3 M ÿ1 . Since typical values of p(d) are of the order of 1 mM, the resulting value of K i will be ;1. Such a K i will ensure that the PRP binding site is unoccupied by the internal ligand for a substantial fraction of time, thereby allowing for the displacement of the internal ligand by an external ligand. The 10 3 M ÿ1 order of magnitude for K e0 values of the Tec family kinases thus seems important for regulatory purposes.
Effects of intramolecular PRP binding on folding of S19P20s and HcK SH3 domains
Matrin-Sierra et al. (28) linked the P41 PRP sequence A 1 PSYSPPPPP 10 to the C-terminal of the circular permutant S19P20s of the a-spectrin SH3 domain and studied the effect on folding stability. The bimolecular binding constant of the PRP to S19P20s was K e0 ¼ 6.3 3 10 3 M ÿ1 . The structure of the P41-S19P20s complex can be modeled after the complex of P41 with the Abl SH3 domain (PDB entry No. 1bbz) (41 54 , and Y 57 ) in S19P20s (PDB entry No. 1tuc) (42) with a backbone RMSD of only 0.2 Å . With this superposition, the C-terminal of S19P20s (E 17 C a ) and the N-terminal of the P41 N-terminal (A 1 C a ) is 12.9 Å (Fig. 3 b) . These two residues were connected by the linker sequence SGDN, resulting in a linker length of five peptide bonds. For the 
upon covalently linking the GAP PRP for intramolecular binding. If we assume that the folding rate is unaffected by the covalent linking, then the unfolding rate should be reduced by the above factor. By mass spectroscopy Gmeiner et al. (27) found a factor of ;40 for the slowing down of unfolding. It is possible that the experimental value for the decrease in unfolding was underestimated, as mass spectroscopy after H/D exchange might actually probe local instead of global unfolding. Fig. 3 c shows that the internal PRP of Hck kinase is not as closely packed against the SH3 domain as the Tip PRP is. The internal PRP has the sequence K 249 PQKPWE 256 and the two lysine residues appear to be responsible for the loose packing. Lerner et al. (20) found that mutating them into prolines significantly increases the intramolecular binding affinity. To use Eq. 17b to predict K e , we need the distances between P 10 of 3BP-2 and the attachment point of the SH3-SH2 linker on the SH3 domain and between P 1 of 2BP-1 and the attachment point of the SH3-SH2 linker on the SH2 domain. We take the two attachment points to be P 137 and W 146 (residue numbering according to PDB entry No. 2abl; Fig. 4 a) 
. This is ;20-fold too high relative to the measured value. It is possible that the orientations of the SH3 and SH2 domains are not totally random, as we have modeled, upon binding the bivalent ligand. Orientational correlation will reduce
and hence the predicted K e value.
Profit et al. (31, 32) connected an SH2-targeting peptide (Y p )EEIE with a kinase active-site directed inhibitor EE-LL(F 5 Phe) by a tether consisting of g-aminobutyric acid (GABA) residues. The ligands separately have binding constants K ea0 ¼ 10 6 and 1.7 3 10 3 M ÿ1 for the Src SH2 and kinase domains. The bivalent inhibitor with the highest affinity, 2.1 3 10 5 M ÿ1 , has F 5 Phe and Y p linked by three GABA residues. In an active conformation of Src kinase in which the SH2 domain is dislocated from the kinase domain (PDB entry No. 1y57) (6), the SH2 binding site and the kinase active site are ;60 Å away (Fig. 4 b) . The two domains must rearrange significantly to bring the two binding sites much closer to accommodate the bivalent ligand.
To apply Eq. 17b to predict K e , we take the linker between the SH2 and kinase domains to be between residues P 246 and W 260 (residue numbering according to PDB entry No. 1y57 (6) (Fig. 4 b) ). The structure of the complex between the SH2 domain and (Y p )EEIE has been determined (PDB entry No. 1shd) (48) . The distance between P 246 and Y p in this complex is d 1 ¼ 22.8 Å . No structure for EELL(F 5 Phe) bound to the kinase domain can be found. We therefore take the inhibitor found in 1y57 as a model of EELL(F 5 Phe) for the purpose of calculating the distance d 2 and the orientation of the bound ligand. Specifically, d 2 is measured between P 246 and atom C8 of the inhibitor in 1y57 and found to be 24.8 Å ; the vector from atom C8 to atom C9 of the inhibitor is used to constrain the direction of the linker. With linker lengths of L 1 ¼ 14 and
This again is ;20-fold too high relative to the measured value.
Vidal et al. (35) constructed a bivalent ligand for the two SH3 domains of Grb2 by linking the C-terminals of two copies of V 1 PPPVPPRRR 10 . Individually the PRP has binding constants K ea0 ¼ 3.8 3 10 5 and 2.5 3 10 4 M ÿ1 for the N-and C-terminal SH3 domains (nSH3 and cSH3) of Grb2. Upon linking two copies of the PRP by a single lysine the bivalent ligand has a binding constant of 2.5 3 10 7 M ÿ1 . In the crystal structure of unbound Grb2 (PDB entry No. 1gri) (49), the two PRP binding sites are .25 Å apart (Fig. 4 c) , and therefore cannot be spanned by a single-residue linker, in contrast to observations of Vidal et al. (35) and Yuzawa et al. (34) . The latter authors also found experimental evidence indicating that, in solution, the two SH3 domains of Grb2 move freely relative to each other and the whole protein is less compact than the crystal structure.
The effective concentration for bivalent binding to Grb2 involves three flexible linkers: the first between nSH3 and the SH2 domain, the second between the SH2 domain and cSH3, and the third between the two PRP ligands (Fig. 4 c) . We take the first linker to be between residues I 53 
Effects of linker length
In addition to the intramolecular binding between the SH3 domain and the PRP within the SH2-kinase linker, the Src family kinases utilize a second mechanism for suppression of kinase activity: binding of a phosphorylated tyrosine on the C-terminal tail to the SH2 domain. concentration and thus a lower bound fraction. As a result the kinase activity would be increased.
Kramer and Karpen (52) developed highly potent polymerlinked ligand dimers for activating cyclic-nucleotide-gated channels and cyclic GMP-dependent protein kinase. They found that each target protein, with a given distance between the two binding sites for a bivalent ligand, has an optimal linker length. As illustrated in Fig. 5 b for the binding of PEG-linked cGMP dimer to olfactory cyclic-nucleotidegated channel, the broad distribution of the binding constant with polymer length is consistent with the effect of linker length on the effective concentration. The structure of the channel is not known. Best fit to the experimental data for binding gives a distance of 30 Å between the two binding sites.
DISCUSSION
We have applied a quantitative relation between intermolecular and intramolecular binding to predict the intramolecular binding constant, the effect of an internal PRP ligand on the folding stability of an SH3 domain, and the enhanced affinity from covalently linking two ligands for separate binding sites. Despite the simplicity of the theoretical model, the predictions generally agree reasonably well with experimental results. These applications lead to several general conclusions, which we now outline.
For an SH3 domain that uses intramolecular PRP binding as a mechanism for regulation, the intramolecular binding constant K i should probably be ;1; values too high or too low would mean that the regulatory switch is on or off all the time. The applications presented here show that the effective concentration p(d) is in the mM range. This requires that the intermolecular binding constant of the internal ligand is of the order of 10 3 M ÿ1 . The requirement for such a low affinity explains why internal PRP ligands often have sequences that deviate significantly from ideal high-affinity sequences, a situation that has been termed ''self-restraint'' (19) . This observation also applies to intramolecular binding of Y 527 p to the SH2 domain of Src Kinase; the affinity of the native Y 527 p sequence has been found to be 10,000-fold lower than that of an ideal SH2 ligand (53) . Other examples of intramolecular binding in regulation include binding of the myristoylated N-terminal of Abl kinase to its kinase domain (8, 54) , binding of the receiver and effector domains of response regulator NarL (55) , and binding of the pocket and C-terminal domains of the retinoblastoma protein (56) .
Addition of ligands that favor the folded state over the unfolded state is a very common strategy for increasing protein stability. For an SH3 domain, covalently linking a PRP with a bimolecular binding constant of ;10 6 M ÿ1 is predicted to increase the folding stability by 15-20 kcal/mol. As the stability of SH3 domains is often relatively low, one wonders whether intramolecular PRP binding provides an in vivo mechanism for stabilization. The same mechanism can apply to the stabilization of other types of protein domains that recognize different peptide motifs.
Covalent linking of two low-affinity ligands may result in a high-affinity bivalent ligand. It has sometimes been suggested that the affinity K e of the bivalent ligand is expected to be the product of the affinities K e10 and K e20 of the separate ligands (29, 57) . Such a product will have units M ÿ2 , inappropriate for a bimolecular binding constant K e . The correct formulation through Eqs. 16b and 17b predicts K e as the product of K e10 K e20 and the effective concentration. The effective concentration depends on the distance between the two binding sites and the linker length. As seen for the binding of PEG-linked cGMP dimer to olfactory cyclicnucleotide-gated channel, for a given distance between the binding sites, the linker length can be optimized. The effective concentration is in the mM range, thus as long as one ligand has an affinity greater than 10 3 M ÿ1 , linking it to another ligand will enhance the affinity of the latter. For example, for two ligands with affinities of 10 5 and 10 6 M ÿ1 , if linking them has an effective concentration of 1 mM for the two binding sites, the expected affinity for the bivalent ligand is 10 8 M ÿ1 , which is 100-to 1000-fold higher than the affinities of the individual ligands.
The mM range of the effective concentration makes it easy to achieve affinity enhancement through covalent linking. Proteins like Src family kinases and Grb2 may actually utilize the separate binding sites on SH3 and SH2 domains for highaffinity bivalent binding. Flexible linkers between the domains allow the proteins to adapt to different targets. Affinity enhancement of bivalent binding has been observed in many other designed and natural systems (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) .
Effect of competitor on dissociation kinetics of bivalent ligand
It is of interest to ask, in enhancing binding affinity, whether covalent linking of two separate ligands exerts its influence through the association rate or the dissociation rate. A previous kinetic analysis showed that the affinity enhancement is mainly manifested through decrease of the dissociation rate (11) . This theoretical result is supported by experimental observations of Kramer and Karpen (52) and Walker et al. (61) .
For a protein that is bound to a monovalent ligand, when a competitor for the ligand is introduced, the rate of exchanging to the competitor is the same as the dissociation rate of the original ligand. If a bivalent ligand behaves the same way, the exchange rate will be exceedingly small, given the effect of covalent linking on the dissociation rate of the bivalent ligand. However, both Kramer and Karpen (52) and Rao et al. (60) observed fast exchange in the presence of excess competitor.
The exchange between a bivalent ligand and a monovalent competitor is illustrated in Fig. 6 . With the elementary rate constants shown, it can be shown that the overall exchange rate constant is
where [C] is the concentration of the competitor. As [C] / N, we have k ex / k 1-, the dissociation rate from one of the two binding sites, which is unaffected by covalent linking. Kramer and Karpen (52) studied the dissociation kinetics of a PEG-linked cGMP dimer from olfactory cyclic-nucleotidegated channel in the presence of cGMP. The dependence of the dissociation rate on cGMP concentration appears to be in qualitative agreement with Eq. 18.
Further refinement of theoretical model
The model for linkers used here considers only statistical distributions of the end-to-end vector. Effects such as excluded-volume and other types of interactions between linkers and protein domains and conformational preferences of specific sequences may affect the effective concentration. Such detailed effects can be captured by molecular dynamics or Monte Carlo simulations. Given the encouraging results presented here, such further refinements seem well justified and will be pursued in the future. In summary, based on a quantitative relation between intermolecular and intramolecular binding, we have calculated the intramolecular binding constant of the Itk SH3 domain with an internal PRP, the stabilization of a circular permutant of the a-spectrin SH3 domain by intramolecular binding of a designed PRP, and the affinity enhancement of a bivalent ligand for the two SH3 domains of Grb2. These and other examples suggest that flexible linkers and sequence motifs tethered to them, like folded protein domains, are also subject to tight control during evolution.
